bioAffinity Technologies, Inc. (NASDAQ:BIAFW) Short Interest Update

bioAffinity Technologies, Inc. (NASDAQ:BIAFWGet Free Report) was the target of a significant growth in short interest in the month of June. As of June 15th, there was short interest totalling 1,300 shares, a growth of 160.0% from the May 31st total of 500 shares. Based on an average trading volume of 1,700 shares, the days-to-cover ratio is currently 0.8 days.

bioAffinity Technologies Price Performance

NASDAQ:BIAFW traded down $0.23 during midday trading on Friday, hitting $0.30. 1,000 shares of the stock were exchanged, compared to its average volume of 3,615. The business has a 50-day moving average price of $0.39 and a two-hundred day moving average price of $0.31. bioAffinity Technologies has a one year low of $0.05 and a one year high of $0.90.

About bioAffinity Technologies

(Get Free Report)

bioAffinity Technologies, Inc, a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat lung cancer and other diseases of the lung at the cellular level.

Featured Articles

Receive News & Ratings for bioAffinity Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for bioAffinity Technologies and related companies with MarketBeat.com's FREE daily email newsletter.